Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

171.97
Delayed Data
As of Aug 26
 +1.74 / +1.02%
Today’s Change
130.09
Today|||52-Week Range
176.64
+5.94%
Year-to-Date
These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Bil...
9:14am / MotleyFool.com - Paid Partner Content
3 Cheap Dividend Stocks You Can Buy Right Now
Aug 19 / MotleyFool.com - Paid Partner Content
Amgen's Shameful Silence Covers Up Reasons for FDA Drug Rejection
Aug 25 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen
Aug 18 / Zacks.com - Paid Partner Content
Amgen Gets CRL for Secondary Hyperparathyroidism Drug
Aug 25 / Zacks.com - Paid Partner Content
Cytokinetics' Amyotrophic Lateral Sclerosis Study Enrolled
Aug 18 / Zacks.com - Paid Partner Content
J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
Aug 24 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content